# German American Bancorp, Inc.: overview

GABC · Nasdaq · CIK 714395 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gabc.md) · [Financials](/companies/gabc/financials.md) · [Filings](/companies/gabc/filings.md) · [Insiders](/companies/gabc/insiders.md)

Latest reported revenue: [$126.9m](/filings/0000714395-26-000032.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:Revenues, accession 0000714395-26-000032).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [88.5](/filings/0000714395-25-000053.md) | [90.7 d](/filings/0000714395-26-000011.md) | [111](/filings/0000714395-26-000027.md) | [123](/filings/0000714395-26-000032.md) | [127](/filings/0000714395-25-000053.md) | [127 d](/filings/0000714395-26-000011.md) | [123](/filings/0000714395-26-000027.md) | [127](/filings/0000714395-26-000032.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [23.8%](/filings/0000714395-25-000053.md) | [25.6% d](/filings/0000714395-26-000011.md) | [9.5%](/filings/0000714395-26-000032.md) | [25.5%](/filings/0000714395-26-000032.md) | [27.7%](/filings/0000714395-25-000053.md) | [28.2% d](/filings/0000714395-26-000011.md) | [27.0%](/filings/0000714395-26-000032.md) | [30.1%](/filings/0000714395-26-000032.md) |
| Diluted EPS | $ per share | [0.71](/filings/0000714395-25-000053.md) | not reported | [0.30](/filings/0000714395-26-000027.md) | [0.84](/filings/0000714395-26-000032.md) | [0.94](/filings/0000714395-25-000053.md) | not reported | [0.88](/filings/0000714395-26-000027.md) | [1.02](/filings/0000714395-26-000032.md) |
| Free cash flow | $m | [23.0 d](/filings/0000714395-25-000053.md) | [28.0 d](/filings/0000714395-26-000011.md) | [36.7](/filings/0000714395-26-000027.md) | [26.2 d](/filings/0000714395-26-000032.md) | [50.1 d](/filings/0000714395-25-000053.md) | [41.0 d](/filings/0000714395-26-000011.md) | [36.0](/filings/0000714395-26-000027.md) | [55.3 d](/filings/0000714395-26-000032.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [278](/filings/0000714395-25-000012.md) | [317](/filings/0000714395-26-000011.md) | [354](/filings/0000714395-26-000011.md) | [487](/filings/0000714395-26-000011.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | [29.4%](/filings/0000714395-25-000012.md) | [27.1%](/filings/0000714395-26-000011.md) | [23.7%](/filings/0000714395-26-000011.md) | [23.1%](/filings/0000714395-26-000011.md) |
| Diluted EPS | $ per share | [3.17](/filings/0000714395-24-000014.md) | [2.78](/filings/0000714395-25-000012.md) | [2.91](/filings/0000714395-26-000011.md) | [2.83](/filings/0000714395-26-000011.md) | [3.06](/filings/0000714395-26-000011.md) |
| Free cash flow | $m | [96.2](/filings/0000714395-24-000014.md) | [102](/filings/0000714395-25-000012.md) | [101](/filings/0000714395-26-000011.md) | [90.7](/filings/0000714395-26-000011.md) | [154](/filings/0000714395-26-000011.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/gabc/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $142.2m | 2,995,249 |  | Added +288,780 |
| [FRANKLIN RESOURCES INC](/funds/38777.md) | 2026-06-30 | $93.0m | 1,960,565 |  | Added +80,019 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $73.3m | 1,544,442 |  | Added +21,287 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $60.3m | 1,270,252 |  | Added +117,557 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $60.0m | 1,265,181 |  | Added +45,223 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $47.6m | 1,002,126 |  | Added +62,168 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $46.9m | 988,330 |  | Added +69,267 |
| [GERMAN AMERICAN BANCORP, INC.](/funds/714395.md) | 2026-06-30 | $45.2m | 951,402 |  | Reduced −15,470 |
| [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $27.6m | 582,529 |  | Added +34,077 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $25.1m | 529,361 |  | Added +36,052 |

## Recent filings

[All 2,295 filings](/companies/gabc/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-08 | 16:39 ET | [8-K](/filings/0000714395-26-000039.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000714395-26-000039 |
| 2026-08-06 | 15:31 ET | [10-Q](/filings/0000714395-26-000032.md) | Quarterly report, period 2026-06-30 | 0000714395-26-000032 |
| 2026-07-27 | 16:25 ET | [8-K](/filings/0000714395-26-000030.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000714395-26-000030 |
| 2026-05-06 | 17:15 ET | [10-Q](/filings/0000714395-26-000027.md) | Quarterly report, period 2026-03-31 | 0000714395-26-000027 |
| 2026-05-06 | 16:05 ET | [8-K](/filings/0000714395-26-000022.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000714395-26-000022 |
| 2026-04-29 | 13:58 ET | [8-K](/filings/0000714395-26-000019.md) | 5.07 Shareholder vote results | 0000714395-26-000019 |
| 2026-04-27 | 16:23 ET | [8-K](/filings/0000714395-26-000016.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000714395-26-000016 |
| 2026-03-18 | 09:07 ET | [DEF 14A](/filings/0001104659-26-030015.md) | Proxy statement, period 2026-04-27 | 0001104659-26-030015 |
| 2026-03-05 | 16:21 ET | [8-K](/filings/0000714395-26-000013.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000714395-26-000013 |
| 2026-02-27 | 17:50 ET | [10-K](/filings/0000714395-26-000011.md) | Annual report, period 2025-12-31 | 0000714395-26-000011 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000714395-26-000011.md), filed Feb 27, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/6b7ebded-2e91-4438-91ee-017a57ecff76)

## About the filer

- CIK: 714395
- Tickers: GABC
- Exchange: Nasdaq
- SIC code: 6022 State Commercial Banks
- State of incorporation: IN
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 16:28 ET. No prices; not investment advice.